During this segment, Dennis Patrick Scanlon, PhD, invites the panelists to discuss whether a common ground can be achieved between state-run Medicaid agencies and private employer-run programs, with respect to value-based purchasing.
Francois de Brantes, MS, MBA, emphasizes a need for aggressive management of healthcare costs, pointing to several innovative state-run programs. These programs, says Mr de Brantes, have increased resident tax rates and have resulted in push-back. “The state government will have to find a way to react to that,” he adds.
As for private payers following the Medicare lead, Arthur Vercillo, MD, FACS, indicates that innovative private payer plans are often met with skepticism. Private payers introducing a new policy are often questioned by providers on CMS recommendations said Dr Vercillo; there is wider acceptance if the program comes directly from CMS instead of the private payer. Ateev Mehrotra, MD, MPH, agreed that it is difficult to do what Medicare—a dominant payer in many services—does.
Indicating that there is more innovation in the private sector, Dr Vercillo thinks that the Affordable Care Act will allow for increased collaboration among stakeholders.
Dr Scanlon asks the panelists the provider perception of these programs and whether they feel threatened that their practice may not meet the value standards. “Do providers need to change the way in which they practice to extract greater value?” he asks.
With an anecdote, Dr Vercillo suggests that all parties including patients, provides, and payers, have to work together. He goes on to emphasize the value of measuring data and comparing it to benchmarked standards and data from other providers to evaluate performance.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More